search
Back to results

ReAL Trial (Rectal Anastomotic seaL) (ReAL)

Primary Purpose

Rectal Cancer

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Cyanoacrylate reinforcement
No reinforcement
Sponsored by
Societa Italiana di Chirurgia ColoRettale
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rectal Cancer focused on measuring colorectal anastomosis, leakage

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Resectable, histologically proven primary adenocarcinoma of the High-medium rectum without internal and/or external sphincter muscle involvement.
  • Distal margin of the tumor at least 8 cm form the anal verge
  • Staged as follows prior to neoadjuvant chemoradiation: Stage T2 - T4 at MRI
  • Patient classified T3-T4 will undergo neoadjuvant chemoradiation if the cancer is located in the extraperitoneal rectum

Exclusion Criteria:

  • Squamous cell carcinoma
  • Adenocarcinoma Stage T1,
  • T4 with one of the following: with pelvic side wall involvement, requiring sacrectomy, requiring prostatectomy (partial or total)
  • Unresectable primary rectal cancer or Inability to complete R0 resection.
  • Rectal cancer under 8 cm from the anal verge requiring colo-anal or ultra low rectal anastomosis
  • Recurrent rectal cancer
  • Previous pelvic malignancy
  • Inability to sign the informed consent

Sites / Locations

  • Dept of Emergency and Organ transplantation - University of BariRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Cyanoacrylate

No reinforcement

Arm Description

the anastomotic reinforcement with nebulized cyanoacrylate glue using the special short catheter device for open surgery or the laparoscopic catheter.

No reinforcement will be applied on the anastomosis line

Outcomes

Primary Outcome Measures

Anastomotic leak
leakage of the colorectal anastomosis clinically proven or with two sides X-ray

Secondary Outcome Measures

length of hospital stay
duration of hospital stay
Blood loss
the amount of bleeding during the operation
Surgical site infection
purulent discharge from the wound with positive culture
Postoperative complications
complications after the operation

Full Information

First Posted
May 6, 2019
Last Updated
October 19, 2020
Sponsor
Societa Italiana di Chirurgia ColoRettale
search

1. Study Identification

Unique Protocol Identification Number
NCT03941938
Brief Title
ReAL Trial (Rectal Anastomotic seaL)
Acronym
ReAL
Official Title
Prevention of Anastomotic Leak in Colorectal Surgery by Glue Reinforcement. A Prospective Randomized Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Unknown status
Study Start Date
May 2, 2019 (Actual)
Primary Completion Date
December 2, 2020 (Anticipated)
Study Completion Date
July 2, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Societa Italiana di Chirurgia ColoRettale

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The problem of anastomotic leak is particularly relevant in rectal surgery. Many risk factors have been recognized in the onset of this complication. Preventing the anastomotic leak can bring benefits to the patient and the health system. Several attempts have been proposed to reduce the risk of anastomotic leakage in rectal cancer surgery including suture protection with omental flap and external suture reinforcement by biological glue or mesh. Cyanoacrylate (Glubran 2®) is a synthetic glue with sealing, adhesive and hemostatic properties widely used in surgery. The sealing effect creates an antiseptic barrier against bacteria. The hypothesis is that the application of nebulized cyanoacrylate to the colo-rectal anastomosis in open or laparoscopic/robotic rectal surgery can prevent the leakage
Detailed Description
Colorectal cancer (CRC) is the second most common cause of cancer-related death in male and the third in females in Western Countries accounting for more than 500,000 deaths in 2013 worldwide. One of the most worrying postoperative complication in colorectal surgery is the anastomotic leak which can occur in about 10-15% of the cases. This complication severely impact clinical outcomes with increased risk of death or permanent stoma, higher risk of local recurrence) and relevant increase in hospital costs (length of hospital stay, admission to intensive care, re-interventions). The problem of anastomotic leak is particularly relevant in rectal surgery. The more distal the anastomosis, the higher the likelihood of failure, with resection of a distal rectal cancer having almost a five-fold increased risk of anastomotic leak compared with resection for colon cancer. In fact, anastomotic Leakage (AL) is the most severe complication after Low anterior resection of rectum for cancer, occurring between 3 and 24 % of patients. Many risk factors have been recognized in the onset of this complication, including gender (male patient have a higher anastomotic leak rate), malnutrition, obesity an diabet, american society anesthesiologists (ASA) score, tobacco use, cardiovascular disease, immunosuppression, use of NSAID, preoperative pelvis radiation. Other intraoperative risk factors considered are the splenic flexure mobilization with proximal ligation of the inferior mesenteric artery (IMA), positive intraoperative Air-Leak Test and the perfusion of the anastomosis. Temporary fecal diversion has also been suggested (although a diverting stoma mitigates the clinical consequences of an anastomotic leak but does not prevent it. Other intraoperative technical factors include the use of single or double stapled anastomotic techniques, with or without transanal reinforcing sutures. Therefore, preventing the anastomotic leak can bring benefits to the patient and the health system. All the risk factors described above represent the rationale that justifies the use of intraoperative procedures to prevent the anastomotic leak, such as additional manual stiches to the mechanical suture and / or patches of collagen (proper reinforcement or buttressing) or of sealants. Several attempts have been proposed to reduce the risk of AL in rectal cancer surgery including suture protection with omental flap and external suture reinforcement by biological glue or mesh. Some Authors have reported good results of reinforcement of the colon anastomosis with cyanoacrylate glue. in a porcine model. Cyanoacrylate is a synthetic glue with sealing, adhesive and haemostatic properties widely used in surgery. Furthermore the sealing effect creates an antiseptic barrier against bacteria. Several clinical studies have described the utility of cyanoacrylate glue mainly in vascular surgery, urology and bariatric surgery. Considering its mechanical, physical, biological properties and its safety, cyanoacrylate glue could facilitate the healing of the colorectal anastomosis reducing leak rate, without negative effects on perfusion. The hypothesis is that the application of nebulized cyanoacrylate to the colo-rectal anastomosis in open or laparoscopic/robotic rectal surgery can prevent the leakage

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectal Cancer
Keywords
colorectal anastomosis, leakage

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
140 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cyanoacrylate
Arm Type
Experimental
Arm Description
the anastomotic reinforcement with nebulized cyanoacrylate glue using the special short catheter device for open surgery or the laparoscopic catheter.
Arm Title
No reinforcement
Arm Type
Active Comparator
Arm Description
No reinforcement will be applied on the anastomosis line
Intervention Type
Procedure
Intervention Name(s)
Cyanoacrylate reinforcement
Intervention Description
Anastomosis Reinforcement with with nebulization of 1cc of glue on the anastomosis line
Intervention Type
Procedure
Intervention Name(s)
No reinforcement
Intervention Description
Nothing applied on the anastomosis line
Primary Outcome Measure Information:
Title
Anastomotic leak
Description
leakage of the colorectal anastomosis clinically proven or with two sides X-ray
Time Frame
30 days
Secondary Outcome Measure Information:
Title
length of hospital stay
Description
duration of hospital stay
Time Frame
30 days
Title
Blood loss
Description
the amount of bleeding during the operation
Time Frame
1 day
Title
Surgical site infection
Description
purulent discharge from the wound with positive culture
Time Frame
30 days
Title
Postoperative complications
Description
complications after the operation
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Resectable, histologically proven primary adenocarcinoma of the High-medium rectum without internal and/or external sphincter muscle involvement. Distal margin of the tumor at least 8 cm form the anal verge Staged as follows prior to neoadjuvant chemoradiation: Stage T2 - T4 at MRI Patient classified T3-T4 will undergo neoadjuvant chemoradiation if the cancer is located in the extraperitoneal rectum Exclusion Criteria: Squamous cell carcinoma Adenocarcinoma Stage T1, T4 with one of the following: with pelvic side wall involvement, requiring sacrectomy, requiring prostatectomy (partial or total) Unresectable primary rectal cancer or Inability to complete R0 resection. Rectal cancer under 8 cm from the anal verge requiring colo-anal or ultra low rectal anastomosis Recurrent rectal cancer Previous pelvic malignancy Inability to sign the informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Donato Altomare, MD
Phone
+39 3397593066
Email
donatofrancesco.altomare@uniba.it
First Name & Middle Initial & Last Name or Official Title & Degree
Arcangelo Picciariello, MD
Phone
+393492185104
Email
arcangelopicciariello@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Donato Altomare, Prof
Organizational Affiliation
Societa Italiana di Chirurgia ColoRettale
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Arcangelo Picciariello, MD
Organizational Affiliation
Societa Italiana di Chirurgia ColoRettale
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept of Emergency and Organ transplantation - University of Bari
City
Bari
ZIP/Postal Code
70124
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Donato F Altomare, Prof
Email
donatofrancesco.altomare@uniba.it
First Name & Middle Initial & Last Name & Degree
Donato Altomare, MD
First Name & Middle Initial & Last Name & Degree
Arcangelo Picciariello, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
27247539
Citation
Thomas MS, Margolin DA. Management of Colorectal Anastomotic Leak. Clin Colon Rectal Surg. 2016 Jun;29(2):138-44. doi: 10.1055/s-0036-1580630.
Results Reference
result
PubMed Identifier
17115313
Citation
de la Portilla F, Zbar AP, Rada R, Vega J, Cisneros N, Maldonado VH, Utrera A, Espinosa E. Bioabsorbable staple-line reinforcement to reduce staple-line bleeding in the transection of mesenteric vessels during laparoscopic colorectal resection: a pilot study. Tech Coloproctol. 2006 Dec;10(4):335-8. doi: 10.1007/s10151-006-0303-0. Epub 2006 Nov 27. Erratum In: Tech Coloproctol. 2009 Mar;13(1):103.
Results Reference
result
PubMed Identifier
26116395
Citation
Wiggins T, Markar SR, Arya S, Hanna GB. Anastomotic reinforcement with omentoplasty following gastrointestinal anastomosis: A systematic review and meta-analysis. Surg Oncol. 2015 Sep;24(3):181-6. doi: 10.1016/j.suronc.2015.06.011. Epub 2015 Jun 17.
Results Reference
result
PubMed Identifier
28595813
Citation
Boersema GSA, Vennix S, Wu Z, Te Lintel Hekkert M, Duncker DGM, Lam KH, Menon AG, Kleinrensink GJ, Lange JF. Reinforcement of the colon anastomosis with cyanoacrylate glue: a porcine model. J Surg Res. 2017 Sep;217:84-91. doi: 10.1016/j.jss.2017.05.001. Epub 2017 May 10.
Results Reference
result
PubMed Identifier
11085384
Citation
Montanaro L, Arciola CR, Cenni E, Ciapetti G, Savioli F, Filippini F, Barsanti LA. Cytotoxicity, blood compatibility and antimicrobial activity of two cyanoacrylate glues for surgical use. Biomaterials. 2001 Jan;22(1):59-66. doi: 10.1016/s0142-9612(00)00163-0.
Results Reference
result
PubMed Identifier
24155114
Citation
Wu Z, Boersema GS, Vakalopoulos KA, Daams F, Sparreboom CL, Kleinrensink GJ, Jeekel J, Lange JF. Critical analysis of cyanoacrylate in intestinal and colorectal anastomosis. J Biomed Mater Res B Appl Biomater. 2014 Apr;102(3):635-42. doi: 10.1002/jbm.b.33039. Epub 2013 Oct 24.
Results Reference
result

Learn more about this trial

ReAL Trial (Rectal Anastomotic seaL)

We'll reach out to this number within 24 hrs